Company intelligence / Profile preview
Takgene
Irantakgene.com ↗
- Ownership
- Private
- Employees
- ~300
- Development stage
- Other
01
Overview
Takgene commercializes more than ten licensed probiotic products in Iran, including first-in-class products such as probiotic therapies targeting fatty liver disease, and is advancing two probiotic medicines for MS and Alzheimer's into the market after regulatory approval. It also produces products for respiratory diseases, including flu, and has shown strong pandemic response with its Bio Boost product.[1][2]
- Therapeutic areas
- EndocrinologyWomen's HealthGastroenterologyNeurologyPulmonology
- Modalities
- ProbioticLive biotherapeutic product therapy
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Beyond the preview
Go deeper on Takgene.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Takgene.